Elevating Innovation and Trust in Life Science
Frank Dolan is on a mission. Based on his experience at several biopharma companies, he believes companies can be more innovative in bringing products to market.
He made clear that innovation has been great in developing new therapies. It’s what happens after that where he sees room for improvement.
We also talked about the reputation of the pharma industry. Last year it was at the bottom of a Gallup survey on how industries are viewed (positively or negatively).
Frank suggests:
If there's one takeaway that your C-level executive in biotech and pharma needs to put their arms around in a demonstrated way beyond our history, is that to tell the story of our people and our journey. Of our companies, of our innovation, of our employees… Those stories are amazing.
How are you telling your stories?
Schedule a 15 minute chat with Chris about content.
About My Guest …
Frank Dolan is the Founder and CEO of Arsenal Advisors. He is on a mission to elevate trust, transparency, and effectiveness in life science.
